This company has been acquired
LHC Group Crecimiento futuro
Future controles de criterios 4/6
Información clave
37.2%
Tasa de crecimiento de los beneficios
35.5%
Tasa de crecimiento del BPA
Crecimiento de los beneficios de Healthcare | 17.3% |
Tasa de crecimiento de los ingresos | 8.9% |
Rentabilidad financiera futura | 8.6% |
Cobertura de analistas | Good |
Última actualización | n/a |
Actualizaciones recientes sobre el crecimiento futuro
Recent updates
LHC Group GAAP EPS of $0.35 misses by $0.95, revenue of $576.2M misses by $29.82M
Aug 03LHC Group: UnitedHealth Merger Is Worth Playing
Jul 19FTC second request in LHC Group/UnitedHealth said to probe pay, labor market
Jul 06These 4 Measures Indicate That LHC Group (NASDAQ:LHCG) Is Using Debt Safely
Feb 24With EPS Growth And More, LHC Group (NASDAQ:LHCG) Is Interesting
Feb 06LHC Group (NASDAQ:LHCG) Has A Rock Solid Balance Sheet
Nov 25Is Now The Time To Put LHC Group (NASDAQ:LHCG) On Your Watchlist?
Nov 07Why We Think Shareholders May Be Considering Bumping Up LHC Group, Inc.'s (NASDAQ:LHCG) CEO Compensation
Jun 03LHC Group, Inc. 2021 Q1 - Results - Earnings Call Presentation
May 10With EPS Growth And More, LHC Group (NASDAQ:LHCG) Is Interesting
Mar 25Are LHC Group, Inc.'s (NASDAQ:LHCG) Fundamentals Good Enough to Warrant Buying Given The Stock's Recent Weakness?
Mar 07Is LHC Group, Inc. (NASDAQ:LHCG) Trading At A 45% Discount?
Feb 17Does LHC Group (NASDAQ:LHCG) Have A Healthy Balance Sheet?
Feb 04LHC Group, Inc. (NASDAQ:LHCG) Insiders Have Been Selling
Jan 19Here's Why LHC Group's (NASDAQ:LHCG) Statutory Earnings Are Arguably Too Conservative
Jan 06Here's Why We Think LHC Group (NASDAQ:LHCG) Is Well Worth Watching
Dec 24Did You Miss LHC Group's (NASDAQ:LHCG) Whopping 338% Share Price Gain?
Dec 12LHC Group, Inc. (NASDAQ:LHCG) Stock's Been Sliding But Fundamentals Look Decent: Will The Market Correct The Share Price In The Future?
Nov 30Estimating The Fair Value Of LHC Group, Inc. (NASDAQ:LHCG)
Nov 18LHC Group, Inc. 2020 Q3 - Results - Earnings Call Presentation
Nov 09Previsiones de crecimiento de beneficios e ingresos
Fecha | Ingresos | Beneficios | Flujo de caja libre | Flujo de caja operativo | Núm. de analistas medio |
---|---|---|---|---|---|
12/31/2024 | 2,580 | 155 | N/A | N/A | 4 |
12/31/2023 | 2,446 | 146 | 182 | 182 | 8 |
12/31/2022 | 2,283 | 40 | 30 | 50 | N/A |
9/30/2022 | 2,308 | 63 | -62 | -39 | N/A |
6/30/2022 | 2,297 | 73 | -119 | -91 | N/A |
3/31/2022 | 2,266 | 101 | -245 | -210 | N/A |
12/31/2021 | 2,220 | 116 | -133 | -100 | N/A |
9/30/2021 | 2,169 | 130 | -16 | 22 | N/A |
6/30/2021 | 2,134 | 117 | 41 | 82 | N/A |
3/31/2021 | 2,075 | 124 | 541 | 599 | N/A |
12/31/2020 | 2,063 | 112 | 463 | 529 | N/A |
9/30/2020 | 2,062 | 103 | 412 | 481 | N/A |
6/30/2020 | 2,060 | 119 | 441 | 508 | N/A |
3/31/2020 | 2,091 | 99 | 30 | 75 | N/A |
12/31/2019 | 2,080 | 96 | 97 | 130 | N/A |
9/30/2019 | 2,059 | 94 | 98 | 127 | N/A |
6/30/2019 | 2,037 | 86 | 110 | 137 | N/A |
3/31/2019 | 2,021 | 77 | 73 | 106 | N/A |
12/31/2018 | 1,810 | 64 | 76 | 109 | N/A |
9/30/2018 | 1,591 | 61 | 36 | 57 | N/A |
6/30/2018 | 1,354 | 51 | 1 | 19 | N/A |
3/31/2018 | 1,109 | 46 | 21 | 32 | N/A |
12/31/2017 | 1,063 | 50 | 22 | 32 | N/A |
9/30/2017 | 1,004 | 41 | 62 | 71 | N/A |
6/30/2017 | 962 | 40 | 72 | 79 | N/A |
3/31/2017 | 926 | 38 | 69 | 85 | N/A |
12/31/2016 | 900 | 37 | 51 | 67 | N/A |
9/30/2016 | 882 | 35 | N/A | 66 | N/A |
6/30/2016 | 854 | 34 | N/A | 43 | N/A |
3/31/2016 | 827 | 33 | N/A | 54 | N/A |
Previsiones de crecimiento futuro de los analistas
Ingresos vs. Tasa de ahorro: LHCG's forecast earnings growth (37.2% per year) is above the savings rate (2.1%).
Beneficios vs. Mercado: LHCG's earnings (37.2% per year) are forecast to grow faster than the US market (14.2% per year).
Beneficios de alto crecimiento: LHCG's earnings are expected to grow significantly over the next 3 years.
Ingresos vs. Mercado: LHCG's revenue (8.9% per year) is forecast to grow faster than the US market (6.9% per year).
Ingresos de alto crecimiento: LHCG's revenue (8.9% per year) is forecast to grow slower than 20% per year.
Previsiones de crecimiento de los beneficios por acción
Rentabilidad financiera futura
ROE futura: LHCG's Return on Equity is forecast to be low in 3 years time (8.6%).